Literature DB >> 26815427

Response to the comment of Brusselaers et al. questioning the clinical benefit of circulating free DNA/neutrophil extracellular traps (cfDNA/NETs) as a laboratory marker for outcome prediction after severe burn injuries.

T Lögters1, J Altrichter2.   

Abstract

Year:  2011        PMID： 26815427     DOI： 10.1007/s00068-011-0127-0

Source DB:  PubMed          Journal:  Eur J Trauma Emerg Surg        ISSN： 1863-9933            Impact factor:   3.693


× No keyword cloud information.
  6 in total

1.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

2.  Development and validation of a model for prediction of mortality in patients with acute burn injury.

Authors: 
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

Review 3.  The clinical value of neutrophil extracellular traps.

Authors:  Tim Lögters; Stefan Margraf; Jens Altrichter; Jindrich Cinatl; Steffen Mitzner; Joachim Windolf; Martin Scholz
Journal:  Med Microbiol Immunol       Date:  2009-08-04       Impact factor: 3.402

4.  Predicting outcomes of burns.

Authors:  J R Saffle
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

5.  Diagnostic accuracy of neutrophil-derived circulating free DNA (cf-DNA/NETs) for septic arthritis.

Authors:  Tim Lögters; Adnana Paunel-Görgülü; Christoph Zilkens; Jens Altrichter; Martin Scholz; Simon Thelen; Rüdiger Krauspe; Stefan Margraf; Teresa Jeri; Joachim Windolf; Marcus Jäger
Journal:  J Orthop Res       Date:  2009-11       Impact factor: 3.494

6.  Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis.

Authors:  Stefan Margraf; Tim Lögters; Jenny Reipen; Jens Altrichter; Martin Scholz; Joachim Windolf
Journal:  Shock       Date:  2008-10       Impact factor: 3.454
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.